Neuronetics, Inc. - stock earnings
STIM Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 7, 2024 AfterMarket | - / -0.3162000000 | - | - / 17.5 million | - |
STIM Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -5.4 million USD | 20.3 million USD |
| 2023Q3 | -9.4 million USD | 17.9 million USD |
| 2023Q2 | -4.9 million USD | 17.6 million USD |
| 2023Q1 | -11.1 million USD | 15.5 million USD |
| 2022Q4 | -8.9 million USD | 18.2 million USD |
| 2022Q3 | -7.8 million USD | 16.5 million USD |
| 2022Q2 | -11.0 million USD | 16.3 million USD |
| 2022Q1 | -11.5 million USD | 14.2 million USD |
| 2021Q4 | -7.6 million USD | 15.0 million USD |
| 2021Q3 | -8.2 million USD | 13.8 million USD |
| 2021Q2 | -7.5 million USD | 14.2 million USD |
| 2021Q1 | -7.9 million USD | 12.3 million USD |
| 2020Q4 | -3.7 million USD | 15.6 million USD |
| 2020Q3 | -3.4 million USD | 12.4 million USD |
| 2020Q2 | -7.8 million USD | 9.7 million USD |
| 2020Q1 | -12.6 million USD | 11.5 million USD |
| 2019Q4 | -7.6 million USD | 17.4 million USD |
| 2019Q3 | -6.9 million USD | 16.0 million USD |
| 2019Q2 | -7.1 million USD | 16.6 million USD |
| 2019Q1 | -7.5 million USD | 12.7 million USD |
| 2018Q4 | -6.1 million USD | 15.6 million USD |
| 2018Q3 | -5.0 million USD | 13.7 million USD |
| 2018Q2 | -7.5 million USD | 13.3 million USD |
| 2018Q1 | -5.5 million USD | 10.2 million USD |
| 2017Q4 | -4.9 million USD | 12.1 million USD |
| 2017Q3 | -3.8 million USD | 10.5 million USD |
| 2017Q2 | -2.9 million USD | 10.3 million USD |
| 2017Q1 | -4.5 million USD | 7.5 million USD |
| 2016Q4 | -11.2 million USD | 9.8 million USD |
| 2016Q3 | ? USD | 8.3 million USD |
| 2016Q2 | ? USD | 9.3 million USD |
| 2016Q1 | ? USD | 6.9 million USD |
STIM Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -30.2 million USD | 71.3 million USD |
| 2022 | -39.2 million USD | 65.2 million USD |
| 2021 | -35.6 million USD | 55.3 million USD |
| 2020 | -32.3 million USD | 49.2 million USD |
| 2019 | -34.3 million USD | 62.7 million USD |
| 2018 | -24.1 million USD | 52.8 million USD |
| 2017 | -16.1 million USD | 40.4 million USD |
| 2016 | -11.2 million USD | 34.2 million USD |
STIM
Price: $3.74
52 week price:
Earnings Per Share: -1.05 USD
P/E Ratio: -3.08
Exchange: NGM
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 51584
Market Capitalization: 131.8 million